Oncodesign Services opens access to ImaginAb’s CD8 ImmunoPET technology
Oncodesign Services, a leading Contract Research Organization specialized in drug discovery and preclinical services in oncology and immuno-inflammation, has executed a Preclinical License and Supply Agreement with ImaginAb for the use of their investigational CD8 ImmunoPET (89Zr crefmirlimab berdoxam) technology. ImaginAb, a biotechnology company, developed CD8 ImmunoPET, a 89Zr PET imaging agent to enable the […]
